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Biologically active compounds from plants have attracted great interest due to their affordability, ef-
fectiveness and low toxicity. Herbal extracts provide an infinite resource of raw materials for pharma-
ceutical, cosmetic and food industry. Unfortunately, use of the valuable natural compounds can be
limited by their low bioavailability, volatilization, sensitivity to the temperature, oxidation and UV
light, in vivo instability, as well as unpleasant taste. One of the potential strategies to overcome
these issues is microencapsulation of the biologically active ingredients. In this review, prepara-
tion, applications and limitations of the most popular techniques for microencapsulation, such as
spray drying, fluid bed coating, encapsulation using supercritical fluids, freeze drying, ionic gela-
tion, emulsification-solvent removal methods and formulation of liposomes, were discussed. Also,
microparticles properties produced by presented microencapsulation methods were interpreted.
Key words: herbal extracts; medicinal plants; microencapsulation; polyphenols; microparticles; antioxidants
http://dx.doi.org/10.5937/leksir1838062M
1. INTRODUCTION
According to the available data, nowdays 80% of the world’s
population uses herbs and herbal medicaments for treatment
of various ailments. The acceptability of herbal formulations
is increasing due to their affordability, effectiveness and low
toxicity (Atul Bhattaram et al., 2002). Unfortunately, use of
the valuable natural compounds can be limited by their un-
pleasant taste, low bioavailability, volatilization, sensitivity
to the temperature, oxidation and UV light, as well as in vivo
instability (C´ujic´ et al., 2013; Abd Manaf et al., 2015; Munin
and Edwards-Levy, 2011). One of the potential strategies to
overcome these issues is microencapsulation of the herbal ac-
tive ingredients. Therefore, microencapsulation technology
can be used for obtaining herbal products with desirable char-
acteristics. Microencapsulation techniques of plant materials
and other natural products are widely used in the food, phar-
maceutical and cosmetic industries.
Microencapsulation is a process by which solids, liquids or
gases are surrounded with a membrane or matrix (Desai and
Jin Park, 2005; Suri et al., 2013). The entrapped material is
known as the core material, actives, fill, internal phase or pay-
load. The coating material can be called the capsule, wall ma-
terial, membrane, carrier or shell (Gibbs et al., 1999). The parti-
cles with sizes ranging from 1 to 1000 µm are called micropar-
ticles or microspheres. There are two types of microparticles;
microcapsules and micromatrices (Figure 1). Microcapsules
are made of one or multiple core substances, surrounded by a
distinct capsule wall. Micromatrices are polymeric matrices
in which the encapsulated substances are homogeneously dis-
persed (Park and Yeo, 2007). Terminology in this field is incon-
sistent, sometimes micromatrices are also called microspheres.
Depending of the entrapped materials properties, core mate-
rials and methods used for preparation, particles with differ-
ent structure, size and shape can be obtained (Poshadri and
Aparna, 2010).
Fig. 1. Two major types of microparticles: microcapsules and micro-
matices
Microencapsulation can be used to enhance different bi-
ologically active compounds properties (Desai and Jin Park,
2005; Singh et al., 2010):
• Improve the stability of the encapsulated bioactive com-
pounds and to extend their shelf life
• Reduce their degradation
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• Enhance physical performance and promote easier han-
dling
• Mask the unpleasant taste of substances
• Prevent interactions
• Enable modified release
• Reduce toxicity
• Improve efficiency and/or compliance (Figure 2)
In order to obtain the products of the desired characteristics,
it is necessary to consider: expected effect of the encapsulated
bioactive substance(s), preferable particle size, density, stabil-
ity requirements for the encapsulated ingredient(s), optimal
concentration of the active principle(s) in microparticles, way
of release and delivery of bioactive molecule(s), coating mate-
rial properties, processing conditions that are expected to be
used for preparation of the microparticle and the cost limits
(Desai and Jin Park, 2005).
Fig. 2. Beneficial effects of microencapsulation application in food
and pharmaceutical industry
2. MICROENCAPSULATION METHODS
Microencapsulated particles can be prepared by several mi-
croencapsulation techniques. The choice of the microencap-
sulation process is governed by the physical and chemical
properties of the core and coating materials and the intended
application. Various encapsulation methods have been pre-
viously used for encapsulation of plant or natural products.
Some of the most popular techniques, such as spray drying,
fluid bed coating, encapsulation using supercritical fluids,
freeze drying, ionic gelation, emulsification-solvent removal
methods and formulation of liposomes are presented in this
review.
2.1. Spray drying
Spray drying is a widely applied method used in the food,
chemical, electronics, pharmaceutical and biopharmaceutical
industry (Jain et al., 2012). In the pharmaceutical industry,
this technique could be applied in case of microencapsula-
tion, granulation and complex formation. Also, spray drying
is successfully used for the modification of biopharmaceuti-
cal properties of drugs and the formulation of dry powder
aerosols and heat sensitive materials. This method is often
used to encapsulate drugs, plant extracts, essential oils and
various biologically active compounds (Belšcˇak-Cvitanovic´
et al., 2015; C´ujic´, 2017; Dias et al., 2017; Peres et al., 2011).
The principle of microencapsulation by spray drying is based
on the dissolution or dispersion of the core material in the
carrier solution, dispersed in the hot air stream. The rapid
evaporation of solvent causes the entrapment of the active
compound into the carrier (Cocero et al., 2009). The solvent
(dispersing agent) quickly evaporates, while the incorporated
substance is briefly exposed to the hot air stream. The par-
ticles are collected after they fall on the bottom of the dryer
(Snyder and Lechuga-Ballesteros, 2008). Numerous proper-
ties of particles can be optimized (particles shape and size,
porosity, bulk density, flow rate, moisture content, etc.) by
choosing the appropriate materials, equipment and process
parameters. The advantages of spray drying: the ability to
obtain the high quality product and to control its properties,
the stability of the obtained product is improved, scale-up is
simple and production costs are relatively low (Miletic, 2013).
During the spray drying process of plant extracts with high
sugar content, adhesion to the walls may occur as a problem,
due to the low temperature of the glass transition of sugars
and organic acids. This problem can be overcome using the
carriers with high glass transition temperature, such as gum
arabic, maltodextrins, starches, proteins, hydrocolloids and
various hydrolysed starches (Tomšik, 2018).
It has been reported that the antioxidant capacity of Quercus
resinosa leaves infusions was high. On the other hand, Quer-
cus resinosa leaves are well known as adstrigens. This plant
material is also unstable due to polyphenolic compounds and
interactions with different food ingredients. For this reason,
the aim of the work by Rocha-Guzman et al. (2010) was to
obtain encapsulated Quercus resinosa leaves infusions with
appropriate stability and masked taste by the spray drying
method. Sodium caseinate and lactose monohydrate were
selected as carriers. Dispersion of lyophilized Quercus resinosa
leaves infusions and wall material were homogenized at 0,
100, 200, and 300 MPa. Wall matrix was made of lactose and
sodium caseinate blends in 3 ratios (110:40, 90:60, and 70:80
g/L). Homogenized dispersions were encapsulated by spray
drying method. The encapsulated particles of the Quercus
resinosa leaves infusions were in the size range from 138.1±1.1
to 269.8±2.9 nm, with significant antioxidant activity.
2.2. Fluid bed coating
The fluid bed encapsulation process involves spraying of the
coating solution into a fluidized solid particles and several cy-
cles of wetting and drying (Guignon et al., 2002). The coating
material forms film over the particle surfaces. When the parti-
cles are fluidized, separation force is exerted to the particles,
which are more or less agglomerated by the spray solution.
Fluid bed processor can generate its inherent separation force,
depending on the operating conditions such as the airflow pat-
tern and the inlet airflow rate. In practice, depending on the
requirement of the final particle size, the optimal processing
conditions should be selected (Park and Yeo, 2007). Coat-
ing material must be thermally stable and it is important to
have acceptable viscosity to enable pumping and atomizing.
Suitable material for encapsulation by this process should be
spherical and dense with a narrow particle size distribution
and good flowability (Zuidam and Shimoni, 2010). The advan-
tage of this procedure is that the solution of the coating agent
can be applied in several layers. Also, there is a possibility of
coating with several different materials during the production
process. However, this method has some disadvantages and
limits. It is difficult to produce particles smaller than 20 µm.
Also, this technique requires large amount of coating materials
(Guignon et al., 2002).
Artificial colorants are often used to improve the sensory prop-
erties of food and pharmaceutical products. However, using
has become controversial because of their toxicological poten-
tial. β-carotene is well-known antioxidant, which can also be
used as a colorant, due to its distinct red-yellow color. On
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the other hand, β-carotene molecules are susceptible to oxida-
tion and thermal degradation. For this reason, the objective
of the study published by Coronel-Aguilera and San Martin-
Gonzalez (2015) was to encapsulate the spray dried emulsion
of β-carotene by fluidized bed coating technology and to eval-
uate the influence of the fluidized bed coating process condi-
tions: the inlet air temperature (60, 70 or 80 °C) and the coating
solution feed rate (7 or 10 mL/min). Encapsulation was per-
formed in a fluidizing system with a Wurster column. Coating
material consisted of a 10% solution of hydroxypropyl cellu-
lose. The particle size was in the range from 48.6 to 69.5 µm.
Smaller particle size was obtained with the higher tempera-
ture and feeding rate. The greatest encapsulation of β-carotene
was achieved in the case of the lowest temperature and lowest
feed rate. This result can be partly explained by the fact that
the high temperature may contribute to β-carotene degrada-
tion. The stability of the obtained particles was studied at 4, 25
and 45 °C during 4 weeks. The temperature showed an effect
on the stability of the tested particles. The loss in β-carotene
content was larger at higher temperatures, in comparison to
lower temperature. The major degradation in this research
was observed during the first week.
2.3. Encapsulation using supercritical fluids
Among the numerous conventional encapsulation processes,
those based on supercritical technologies have attracted the
food and pharmaceutical applications because of the possi-
bility to work with thermolabile products and the ability to
engineer the particle (Keven Silva and Angela A. Meireles,
2014).
Supercritical fluids (SCFs) are fluids on the temperature and
pressure above the critical pressure and temperature values
for the given fluid. This state is often described as a state
between the liquid and gas. SCFs have a density similar to
liquid, compressibility and viscosity as a gases, whereas the
diffusion capacity is higher than that of a liquid (Medarevic´
et al., 2013). Supercritical fluids characteristics can be affected
by changing the pressure and temperature of the given system.
Supercritical carbon dioxide (scCO2) is the supercritical fluid,
widely used since it is a non-toxic, chemically inert gas, with-
out secondary environmental products, making it environ-
mentally friendly and GRAS (GRAS-Generally Recognized as
Safe). scCO2 has other advantages, such as availablity and
affordablity. The supercritical region of scCO2 can be achieved
at moderate pressures and temperatures (Tc = 304.2 K, Pc =
7.38 MPa) making it possible to carry out the process at near-
ambient temperatures, avoiding the degradation of thermo-
labile substances (Cocero et al., 2009). Many different encap-
sulation processes are based on the use of supercritical fluids,
in which SCFs performs different functions: acts as a solvent
(Rapid Expansion of Supercritical Solutions, RESS), antisol-
vent (Supercritical Anti Solvent precipitation, SAS), co-solvent
or solute (Particles from Gas Saturated Solutions, PGSS), pro-
pellant (Carbon dioxide-Assisted Nebulisation with a Bubbler
Dryer CAN-BD), etc. (Martin et al., 2010). The use of scCO2 as
the antisolvent has been explored for different materials, such
as polymers, pharmaceuticals, inorganic compounds, food
and plants bioactives (Keven Silva and Angela A. Meireles,
2014; Sosa et al., 2011).
Catechins present in green tea (Camellia sinensis) have low
bioavailability (2-5%) and extensive clearance. Therefore, a
group of authors (Sosa et al., 2011) encapsulated green tea
polyphenols using a method based on the use of supercritical
fluid, which was acting as an anti-solvent. Acetone was used
to dissolve green tea extract and carrier, biodegradable poly-
mer (poly-e-caprolactone, MW: 25,000). During this study, the
following process parameters influence was examined: the
operating pressure (8–12 MPa) and temperature (283–307 K),
the polymer to solutes concentration (w/w) ratio (4–58), and
the CO2 to solution mass flow rate ratio (4–10). The particles
obtained at a temperature below 290 K were small (about 5±2
µm), with high polyphenol content, which means that the effi-
ciency of the encapsulation was high (60-100%). Polyphenols
dissolution rate from microparticles shows that 30% of the
antioxidants were released rapidly for the first 4 hours, which
was explained by diffusion mechanism, whereas the largest
amount of polyphenols were retained within the crystalline
domains of the polymer matrix and was released gradually
over the next 90 hours, due to the matrix degradation.
2.4. Freeze drying
Freeze drying or lyophilization, is a drying process in which
the solvent or the suspension medium, is frozen and then
sublimed from the solid state directly into the gaseous phase
(Fang and Bhandari, 2012). Prior to drying, active ingredi-
ents and polymers are dissolved or dispersed in the medium.
The freeze drying process is divided into three basic phases:
freezing, primary drying and final (secondary) drying. This
technique is simple and suitable for encapsulation of ther-
mosensitive or unstable substances. Also, the moisture con-
tent of the final product is controllable, and the dried products
generally have appropriate stability and high quality. They
can be easily reconstituted in water, because they have a high
specific surface area and porous structure. The long duration
of the drying phase and the high cost of the process, are the
limitations of this method (Rey and May, 2004; Tang and Pikal,
2004; Fang and Bhandari, 2012).
The properties of the freeze-dried, encapsulated products
could be affected by the operating conditions and wall ma-
terial properties. According to the available literature, most
of these parameters were chosen based on the trial and error
approach (Fang and Bhandari, 2012). Also, the freeze drying
process can be used after the other encapsulation methods,
in order to convert the encapsulated core materials into the
powder form (Stojanovic et al., 2012; C´ujic´ et al., 2016).
Micropartices lyophilization was used in order to improve
the stability of Rubus chamaemorus extract (Laine et al., 2008).
It has been shown that freeze drying process improved the
extract stability, rich with extremely unstable ellagitannins.
2.5. Complex coacervation
The term complex coacervation was introduced by the Dutch
chemist Bungenberg de Jong in 1949. The first patented mi-
croencapsulation process was based on the phenomenon of
complex coacervation (Lakkis, 2016). This method is based
on interactions between water-soluble cationic and anionic
polymers, which form a polymer-rich phase called coacervate
(Munin and Edwards-Levy, 2011). Polymers coacervate could
be formed around the dispersed core particles. The formation
of coacervate as a special phase is a main precondition for
this microencapsulation process. Coacervate can be formed
spontaneously by mixing the cationic and anionic polymers
or by the addition of an anti-solvent, electrolyte, temperature
reduction, adjustment of the medium pH, as well as in the
presence of certain surfactants (Sovilj et al., 2000). The charges
must be large enough to produce coacervate, but not too large
in order to avoid precipitation (Munin and Edwards-Levy,
2011).
Due to anti-inflammatory, antioxidant and antimicrobial prop-
erties propolis could be applied in various products, such as
toothpaste, shampoos, creams, etc. However, its using is lim-
ited due to the solubility only in alcohol, and it has specific
taste and odor. The aim of the study by Nori et al. (2011) was
to encapsulate the propolis extract by a complex coacervation
with soy protein and pectin, without alcohol. The influence
of different pH values (3.5; 4.0; 4.5 and 5) and the influence
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of propolis concentrations (2.5 g/100 mL and 5 g/100 mL),
as well as pectin (2.5 g/100 mL and 5 g/100 mL) and soy
protein concentrations (2.5 g/100 mL and 5 g/100 mL) were
examined. The size of the obtained microcapsules in this re-
search was in the range from 10 to 90 µm, which was expected
for microcapsules produced by complex coacervation. Ac-
cording to the literature, particles size produced by complex
coacervation ranged from 1 to 500 µm. The encapsulation
efficiency of formulation using 2.5 g/100 mL concentration of
encapsulants and core was 72.01±0.01%; whereas microparti-
cles whose encapsulants and core concentration were 5 g/100
mL had slightly lower encapsulation efficiency (66.12±0.01%).
This result was not expected since increase in the concentra-
tion of colloids and the core in solutions was supposed to
promote coacervation and provide higher encapsulation effi-
ciency. In this study, it was also shown that the application of
coacervation was not deleterious for antioxidant compounds.
Furthermore, the antimicrobial activity of the incorporated
extract was preserved. The stability of the microcapsules dur-
ing the 180 days period at 10 and 25 °C was examined. The
conclusion was that these microparticles should be stored at
a temperature of 10 °C in order to preserve the stability of
flavonoids.
2.6. Ionic gelation
Ionic gelation is a physiochemical microencapsulation tech-
nique, which includes cross-linking of polyelectrolytes (or
charged polymers) in the presence of multivalent counter
ions (Park and Yeo, 2007). This process consists of extrud-
ing an aqueous solution of polymer through a syringe nee-
dle or a nozzle, in which the core material is dissolved or
dispersed. Droplets are received in a dispersant phase and
transformed into spherical gel particles, after a reaction of
polyelectrolytes and multivalent counter ions (Munin and
Edwards-Levy, 2011).
Catechins are a class of polyphenolic flavonoids with con-
firmed antioxidant activities and diverse biological properties,
such as anti-inflammatory, vasodilatory, neuroprotective and
chemopreventive effects. On the other hand, catechins are
highly unstable. Various factors influence the stability of cate-
chins. However, pH is the most crucial factor and the rate of
oxidation increases as the pH increases. Therefore, a group of
researchers encapsulated catechins with an ion-based gel pro-
cess (Dube et al., 2010). Catechin and epigallocatin are incor-
porated into chitosan-tripolyphosphate nanoparticles. These
nanoparticles with catechin had an average size of 163±2 nm,
with a polydispersity index of 0.43±0.02 and a zeta potential
of 33±1 mV. In the case of encapsulated epigallocatechin gal-
late, the particle size was 165±2 nm, the polydispersity index
was 0.46±0.2 nm, whereas the zeta potential was 33±1 mV. In
general, the nanoparticles in this research had a mean size
less than 200 nm and had a positive zeta potential exceed-
ing 30 mV. These attributes are favorable for nanoparticles
for oral delivery, since it has been shown that the potential
way of uptake of particles having a mean size below 500 nm
is translocation through the gastrointestinal mucous barrier
and interactions with the absorptive epithelial cells (Florence
and Hussain, 2001). It is stated that the zeta potential of these
particles reflects the aspect of stability and inhibition of par-
ticle aggregation. Also, the high positive zeta potential may
enhance their bioadhesive properties, which may be mediated
through interactions with negatively charged cell surfaces.
The study also showed that it takes 8 hours to reduce the con-
centration of the catechin by 50% in phosphate buffer (pH 7.4),
whereas for encapsulated catechin 50% of the initial concentra-
tion degraded after 24 hours. For epigallocatechin gallate, the
corresponding values were 10 and 40 minutes, respectively.
2.7. Emulsification-Solvent Removal Methods
Microparticles can be produced from an emulsion of two or
more immiscible liquids. The most commonly used methods
are solvent evaporation and the solvent extraction technique.
In the solvent evaporation method, a volatile solvent has a
very low miscibility with water. This technique is based on the
evaporation of the hydrophobic solvent from the emulsion in
which microspheres are formed and the active ingredients are
trapped in the polymer matrix and encapsulated on that way.
First step includes dissolving of the polymer (coating mate-
rial) in the organic solvent. After that, the active principles are
dissolved/dispersed in the obtained polymeric solution. The
mixture is emulsified in a large amount of water containing
surfactants, to obtain an oil-in-water (O/W) emulsion. Evap-
oration of the solvent is achieved by heating under vacuum
and with gentle stirring. This method is not applicable in the
case of volatile compounds encapsulation and in the case of
compounds with high affinity for the continuous phase (Lu
et al., 2016; Munin and Edwards-Levy, 2011).
The solvent extraction technique, also called nanoprecipita-
tion, is a method where solvent is miscible with water in all
proportions. The method involves dissolving/dispersing the
bioactive compounds in a solvent in which the polymer has
previously been dissolved. Then, this phase is injected under
agitation into a continuous aqueous phase containing a surfac-
tant. Nanoparticles are formed by spontaneous diffusion of
solvents into the aqueous phase, while a polymer precipitates
and forms particles with encapsulated active principles (Lu
et al., 2016; Munin and Edwards-Levy, 2011). Following the
solvent removal, the resulting particles are purified, filtered or
centrifuged. Subsequently, they are dried by a conventional
method or by lyophilization (Munin and Edwards-Levy, 2011).
Resveratrol is a natural polyphenolic compound and it has
been reported that resveratrol induces many cellular re-
sponses, including cell cycle arrest, differentiation and apop-
tosis, making it a novel anticancer agent. In the study re-
ported by Shao et al. (2009), the activity of resveratrol in the
free form and encapsulated resveratrol was compared, for the
treatment of invasive brain tumor (malignant gliomas). mPEG-
PCL (methoxy poly (ethylene glycol)-poly(caprolactone)), was
used as a carrier having a hydrophilic and hydrophobic region.
On this way, it is possible to incorporate the hydrophobic com-
pound, such as resveratrol, into the core, which is surrounded
by the hydrophilic chains. Resveratrol nanoparticles were pre-
pared by nanoprecipitation method. The particles obtained
in this study were spherical with smooth surface, the size
of particles was not significantly changed after lyophiliza-
tion (78.3±7.9 nm prior to lyophilization and 87.5±9.59 nm
afterwards). The zeta potential prior to drying was -6.5±1.4;
whereas afterwards it was -5.6±0.7. The efficiency of encap-
sulation was higher than 90%. The resveratrol loading con-
tent was 19.4±2.4%. In vitro release of resveratrol loaded in
nanoparticles indicated that 50% of resveratrol was released
during the first 5 hours, followed by the observed trend of pro-
longed release. In vitro study revealed that higher efficiency
of encapsulated resveratrol can be explained by higher ability
of encapsulated resveratrol penetration in cell membranes in
comparison to the same dose of free resveratrol.
2.8. Liposomes
Liposomes were discovered around 1965 when British hema-
tologist Dr. Bangham described the appearance of liquid crys-
tals of lecithin in contact with water forming structures very
similar to biological membranes. Liposomes are mainly com-
posed of phospholipids and due to their amphipathic nature
they have a strong tendency to form membranes (Bozzuto and
Molinari, 2015). In addition, they are biodegradable and bio-
compatible vesicular systems. Liposomes could be made up
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of one or more lipid bilayers, which surround the core filled
with water. Based on the number of double layers vesicles
liposomes can be classified as: multilamellar vesicles (MLVs),
oligolamellar vesicles and unilamellar vesicles (ULVs). The
specific structure of these carriers makes them suitable for
encapsulating compounds of various physicochemical prop-
erties. Hydrophilic active substances could be incorporated
into the hydrophilic interior, while lipophilic and amphiphilic
compounds could be incorporated into the liposomal lipid
bilayer (Swami et al., 2015). Large aqueous core represents
interior of ULVs, making them suitable for the encapsulation
of hydrophilic molecules. On the other hand, MLVs preferably
entrap lipid-soluble substances (Bozzuto and Molinari, 2015).
Liposome preparation techniques may be divided into 1) bulk
methods, whereby liposomes are obtained through transfer of
phospholipids from an organic phase into an aqueous phase
and 2) film methods, in which lipid films are first deposited on
a substrate and then hydrated to give liposomes. Following
the preparation of liposomes, various methods for particle
size reduction could be used, such as: sonication, extrusion,
freeze–thaw cycles or homogenization (Patil and Jadhav, 2014).
Amarogentin, secoiridoid glycoside, can be potentially used as
antileishmanial agent. Therefore, group of authors evaluated
amoragentin efficacy in the free form and in two vesicular
forms, liposomes and niosomes (Medda et al., 1999). The
amarogentin in both vesicular forms was found to be a more
effective antileishmanial agent compared to the free form. Ex-
periments on hamsters were performed with the equivalent
drug concentration for free, liposomal and niosomal form of
this active principe. Free amarogentin reduced the parasite
load by 34%. Liposomal form reduced the parasite load by
69%, whereas niosomal form reduced the parasite load by
90%.
CONCLUSION
Plants contain large number of compounds of various physico-
chemical, biopharmaceutical, pharmacokinetic and pharmaco-
dynamic properties. For this reason, formulation of the herbal
products with appropriate properties in terms of efficiency,
stability and quality is a complex task. Encapsulation methods
can play a key role in achieving these goals. Review of the
various research results reveals that encapsulation is a method
for protection of natural compounds, increasing their shelf
life. It was shown that encapsulation enables controlled re-
lease and improves bioavailability and efficiency. Moreover, in
some instances encapsulation methods are being used to mask
an unpleasant taste. Microencapsulation technique should
be selected depending on the desirable characteristics of mi-
croparticles (size, entrapment efficacy, drug loading, bioavail-
ability, stability). Although there are plenty possibilities how
to encapsulate a biologically active compound, usually two
or more encapsulation processing steps are required to get
microparticles with preferable characteristics.
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